Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.

Source:http://linkedlifedata.com/resource/pubmed/id/12044984

Download in:

View as

General Info

PMID
12044984